Fluid Medical

Company Overview

Snapshot

Founded in September 2020 by Oren Shuster, Fluid Medical operates with 1–10 employees. The company has secured funding across one round from one investor, Israel MedicUp, to advance its algorithm-based technology for diagnosing pancreatic cysts.

Business overview

Fluid Medical is developing an algorithm-based technology designed to provide accurate clinical diagnoses of pancreatic cysts within minutes. Its solution aims to classify cyst fluid based on physical properties, reducing the need for unnecessary exploratory surgeries for non-cancerous cysts. The company's technology is intended to decrease hospital costs, eliminate patient risks associated with invasive procedures, and enable immediate treatment for malignant cysts via endoscope, thereby improving patient outcomes. Fluid Medical operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Test Diagnostics & Screening, targeting healthcare providers, laboratories, and pharmaceutical companies.

Company Intelligence Q&A

What is Fluid Medical's primary focus?

Fluid Medical is focused on developing an algorithm-based technology for the accurate and rapid diagnosis of pancreatic cysts, aiming to improve patient outcomes and reduce unnecessary medical procedures.

Who founded Fluid Medical?

Fluid Medical was co-founded by Oren Shuster in September 2020.

What problem does Fluid Medical's technology address?

Fluid Medical's technology addresses the need for immediate and accurate classification of pancreatic cyst fluid, which can help reduce the number of unnecessary exploratory surgeries and enable timely treatment for malignant cysts.

What is Fluid Medical's funding status?

Fluid Medical has secured funding in a Seed round from Israel MedicUp.

Which markets does Fluid Medical target?

Fluid Medical targets the healthcare and life sciences markets, specifically serving providers, laboratories, and pharmaceutical companies with its diagnostic solutions.